This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Melanoma in situ of upper limb, including shoulder
CD2_INSITU_MELANOMA_UPPERLIMB
melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
223 |
4. Check minimum number of eventsNone |
223 |
5. Include endpointsNone |
223 |
6. Filter based on genotype QC (FinnGen only) |
223 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ regionis deltoideae
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of upper limb, including shoulder
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of upper limb, including shoulder
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 223 | 131 | 92 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 68.34 | 66.98 | 70.27 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 191
- Matched controls
- 1908
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
273.1
190
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
184.8
133.0
129
21
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
595.2
48.6
46
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
14.1
36.9
67
70
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
46.9
34.1
41
11
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
27.1
33.3
46
22
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
9.9
32.7
73
112
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
17.0
31.2
51
40
L57.0
ICD-10 Finland
Actinic keratosis
6.9
24.2
69
145
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.4
20.6
53
94
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
9.0
20.3
45
63
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
86.9
14.8
16
*
TQW99
NOMESCO Finland
Other minor procedure on skin
6.9
14.4
37
64
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
12.9
14.3
25
22
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.3
14.0
59
180
ZZR00
NOMESCO Finland
Flap of skin
11.8
13.7
25
24
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
5.9
13.3
39
80
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
20.9
13.2
19
10
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
12.6
12
*
S18
ICPC
Laceration/cut
3.0
11.8
113
626
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
11.1
11.3
21
21
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
26.9
11.3
15
6
SPAT1153
SPAT
Removal of sutures
2.9
11.0
89
436
S82
ICPC
Naevus/mole
3.9
10.7
47
146
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
116.0
10.5
11
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
34.6
10.5
13
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
34.6
10.5
13
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.5
10.1
51
178
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
58.0
9.7
11
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
9.7
8.7
17
19
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
17.3
8.7
13
8
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
93.9
8.5
9
*
C43
ICD-10 Finland
Malignant melanoma of skin
93.9
8.5
9
*
D06BB10
ATC
imiquimod; topical
5.9
8.5
23
43
S77
ICPC
Malignant neoplasm of skin
11.5
8.5
15
14
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
8.4
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
23.2
8.1
11
5
ZXC50
NOMESCO Finland
Cryotherapy
6.3
7.4
19
33
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
31.3
7.2
9
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
41.5
6.8
8
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
6.9
6.8
16
25
XQ845
NOMESCO Finland
Dermatoscopy
15.0
6.5
10
7
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
72.1
6.5
7
*
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
+∞
6.3
6
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
9.0
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
119
235
9.71
65.97
2.0
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
183
753
8.97
44.32
4.3
2.2
—
—
—
0
0
(4035726)
54
182
3.60
13.64
1.7
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
79
4.73
13.23
1.5
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
94
586
2.04
6.18
5.9
5.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
135
976
1.97
5.64
6.1
6.1
mmol/l
1.2
1.2
0.64
112
816
(3019225) pH of Specimen
37
168
2.44
5.24
3.5
3.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
125
903
1.87
5.00
6.1
5.4
mmol/l
1.2
1.2
0.69
111
819
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
110
767
1.86
4.89
2.7
2.3
nmol/l
85.4
78.2
1.82
88
670
(3015377) Calcium [Moles/volume] in Serum or Plasma
97
653
1.86
4.80
4.0
3.5
mmol/l
2.3
2.4
0.56
74
573
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
33
148
2.44
4.79
2.6
3.4
ng/l
84.2
81.2
0.10
21
129
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
198
1738
2.24
3.67
18.0
14.7
ml/min/173m2
77.0
77.0
0.01
177
1415
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
27
3.83
3.39
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
72
484
1.72
3.36
1.6
1.6
nmol/l
24.0
21.9
0.37
55
395
(3013707) Erythrocyte sedimentation rate by Westergren method
166
1390
1.76
3.34
4.7
4.1
mm/h
11.4
13.0
0.72
147
1264
(3009542) Hematocrit [Volume Fraction] of Blood
184
1594
1.88
3.23
19.0
16.3
%
39.3
39.5
0.09
125
1081
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
240
1.87
3.01
5.4
4.8
%
34.2
32.8
0.29
19
153
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
202
1818
2.18
3.00
5.5
5.2
mmol/l
2.7
2.7
0.30
170
1635
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
46
2.94
2.97
2.2
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
106
811
1.59
2.88
6.3
5.5
%
0.7
0.6
0.24
100
752
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
198
1775
2.03
2.88
4.9
4.6
mmol/l
4.7
4.6
0.56
166
1611
(3021589) Normoblasts [#/volume] in Blood
108
831
1.58
2.86
10.9
10.3
e9/l
0.0
0.0
0.51
84
678
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
197
1764
2.00
2.86
5.1
4.6
mmol/l
1.5
1.5
0.34
162
1592
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
104
796
1.57
2.80
2.2
2.0
pmol/l
90.3
95.6
0.43
46
381
(3001604) Monocytes [#/volume] in Blood
114
897
1.55
2.69
6.0
5.5
e9/l
0.6
0.6
0.07
88
777
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
198
1789
1.95
2.60
5.2
4.8
mmol/l
5.8
6.0
1.25
161
1614
(3006315) Basophils [#/volume] in Blood
114
902
1.54
2.59
6.0
5.6
e9/l
0.0
0.0
0.05
89
781
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
192
1721
1.83
2.54
6.4
6.0
mmol/mol
38.8
40.4
2.43
162
1584
(3006504) Eosinophils/100 leukocytes in Blood
107
839
1.53
2.51
6.2
5.5
%
2.6
2.8
0.42
101
781
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
337
1.67
2.47
3.7
3.1
ug/l
0.8
0.8
0.15
33
228
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
188
1679
1.76
2.47
6.5
4.7
mu/l
1.8
2.0
0.89
164
1491
(3012095) Magnesium [Moles/volume] in Serum or Plasma
47
305
1.69
2.43
4.8
3.2
mmol/l
0.8
0.8
1.09
40
285
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
209
1934
2.28
2.42
12.5
10.5
u/l
24.9
24.4
0.19
197
1847
(3019069) Monocytes/100 leukocytes in Blood
107
845
1.51
2.39
6.3
5.8
%
8.8
8.7
0.16
100
792
(3013115) Eosinophils [#/volume] in Blood
116
933
1.51
2.37
6.4
5.8
e9/l
0.2
0.2
0.65
91
822
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
110
880
1.49
2.28
4.2
4.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
107
853
1.49
2.25
5.9
5.4
%
58.6
57.5
0.47
101
799
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
189
1704
1.72
2.22
4.7
4.1
mmol/l
1.3
1.3
0.28
152
1529
(3019198) Lymphocytes [#/volume] in Blood
114
923
1.48
2.20
6.2
5.6
e9/l
1.8
2.0
0.62
91
816
(3044640) Blood type and Crossmatch panel - Blood
79
594
1.51
2.19
3.1
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
83
632
1.50
2.17
5.1
4.0
ph
7.4
7.4
0.20
18
130
(3020564) Creatinine [Moles/volume] in Serum or Plasma
207
1925
2.05
2.08
19.3
18.1
umol/l
80.9
78.6
0.42
207
1925
(3002030) Lymphocytes/100 leukocytes in Blood
107
864
1.46
2.05
6.3
5.7
%
26.7
27.2
0.20
101
800
(3013650) Neutrophils [#/volume] in Blood by Automated count
127
1060
1.46
2.05
8.4
9.6
e9/l
4.0
4.1
0.23
102
932
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
198
1821
1.78
1.99
16.6
15.3
mg/l
20.3
23.6
0.61
167
1465
(3013512) EKG study
77
586
1.48
1.99
4.0
4.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
11
4.62
1.95
2.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
36
2.56
1.76
1.2
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
165
1471
1.47
1.73
8.6
7.3
u/l
74.2
79.1
1.27
150
1366
(3000494) Fungus identified in Specimen by Culture
34
222
1.63
1.73
1.9
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
315
1.54
1.71
2.9
2.9
e6/l
3.0
2.7
0.09
24
169
(3024561) Albumin [Mass/volume] in Serum or Plasma
102
837
1.40
1.71
5.0
4.2
g/l
35.2
35.1
0.03
90
784
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
156
1378
1.44
1.70
5.4
3.9
pmol/l
15.1
14.9
0.44
130
1218
(40761511) CBC panel - Blood by Automated count
202
1886
1.75
1.67
16.3
14.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
14
3.63
1.62
1.6
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
98
806
1.39
1.59
14.4
9.5
inr
1.4
1.3
0.58
29
239
(3012441) Differential panel - Pleural fluid
6
20
3.05
1.59
1.7
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
35
236
1.57
1.57
4.4
8.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
204
1916
1.76
1.57
20.1
17.8
mmol/l
4.0
4.0
0.39
199
1856
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
51
2.22
1.53
2.1
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
118
1007
1.36
1.50
2.9
2.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
31
206
1.59
1.48
1.7
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
16
3.17
1.44
1.2
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
16
3.17
1.44
1.0
1.5
u/l
19.6
15.1
—
5
16
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
16
3.17
1.44
1.4
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
328
1.47
1.42
2.8
2.7
e6/l
0.8
1.1
0.32
24
177
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
40
2.30
1.42
1.7
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
23
2.65
1.37
2.2
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
17
2.98
1.36
2.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
28
406
0.65
1.36
4.4
4.5
kg/l
1.0
1.0
—
6
55
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
74
594
1.37
1.36
2.7
2.0
u/l
297.5
208.1
0.38
66
553
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
43
2.14
1.32
1.7
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
63
495
1.38
1.31
3.4
2.8
umol/l
6255.3
6574.9
0.02
57
413
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
41
298
1.46
1.31
1.4
1.3
iu/ml
23.5
30.8
0.31
11
100
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
34
2.40
1.30
3.4
3.5
%
55.5
61.9
—
8
34
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
56
432
1.40
1.30
3.4
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
75
609
1.35
1.27
4.1
3.2
e6/l
18.8
150.7
0.67
56
470
(36304419) Bacteria [Presence] in Urine
68
545
1.36
1.25
3.8
3.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
25
2.44
1.25
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
69
556
1.35
1.22
3.9
3.1
e6/l
1.2
0.6
0.30
52
418
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
19
2.67
1.22
1.2
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
14
79
1.82
1.20
2.3
2.4
u/l
39.4
40.9
0.11
14
70
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
38
2.15
1.19
7.5
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
38
2.15
1.19
2.0
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
113
0.43
1.16
1.0
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.53
1.15
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
130
1154
1.30
1.14
4.0
3.0
u/l
50.9
48.8
0.11
117
1075
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
50
387
1.38
1.14
3.3
2.8
mmol/l
2.5
2.5
0.51
43
343
(3037467) Urinalysis macro (dipstick) panel - Urine
142
1277
1.31
1.12
5.1
4.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
16
97
1.70
1.10
1.4
2.1
g/l
1.1
1.5
0.88
11
83
(3044941) Cell count panel - Synovial fluid
5
21
2.41
1.09
1.4
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
8
149
0.52
1.08
2.9
2.6
kpa
4.0
4.3
—
8
143
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
67
1.84
1.07
1.9
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
46
2.00
1.05
1.4
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
22
2.30
1.04
1.8
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
22
2.30
1.04
1.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
34
2.09
1.04
2.7
2.9
e9/l
3.8
5.1
—
7
34
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
115
1.61
1.03
1.7
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
57
458
1.33
1.02
4.8
4.9
%
20.3
20.9
0.15
28
229
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
497
1.31
0.99
1.5
1.6
mmol/l
1.3
1.3
0.02
46
412
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
83
706
1.28
0.98
4.4
3.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
30
0.00
0.98
0.0
2.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
52
415
1.33
0.98
3.0
1.7
mg/l
0.9
1.4
0.94
40
330
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
116
0.50
0.97
1.3
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
31
0.00
0.97
0.0
2.6
—
4.0
—
0
31
(3035285) Chloride [Moles/volume] in Venous blood
0
31
0.00
0.97
0.0
2.6
—
106.1
—
0
31
(3026008) Bacteria identified in Urine by Culture
74
621
1.29
0.97
3.0
3.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
62
1.81
0.96
1.9
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
37
1.92
0.95
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
37
1.92
0.95
1.3
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
308
1.36
0.95
2.0
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
52
1.76
0.93
1.9
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
83
710
1.27
0.93
5.0
3.8
e6/l
36.7
70.2
1.17
60
502
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
63
1.78
0.92
2.1
2.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
29
2.10
0.90
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
42
1.94
0.89
5.3
2.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
67
562
1.27
0.87
4.0
2.9
mmol/l
7.2
7.3
0.05
48
457
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
166
0.58
0.87
2.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
32
1.90
0.82
2.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
74
1.66
0.80
2.1
3.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
37
290
1.33
0.79
2.2
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
246
1.35
0.78
1.8
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
83
1.60
0.76
2.3
3.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
53
1.73
0.76
1.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
142
1311
1.23
0.75
4.0
4.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
24
2.11
0.75
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
24
2.11
0.75
2.4
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
108
0.54
0.74
4.2
3.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
55
1.66
0.74
1.3
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
25
2.02
0.73
1.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
41
1.73
0.70
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
43
520
0.79
0.70
5.4
4.3
estimate
0.0
0.0
0.00
24
181
(3012516) Albumin [Mass/volume] in Urine
64
550
1.23
0.67
3.8
3.1
mg/l
19.8
156.5
0.65
34
364
(3020779) Urea [Moles/volume] in Serum or Plasma
20
147
1.40
0.64
13.6
6.7
mmol/l
14.3
10.0
0.83
20
139
(3022145) Colonoscopy Study observation
29
227
1.32
0.64
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
68
592
1.21
0.63
5.9
5.4
ug/l
11.4
2.7
0.45
58
526
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
113
1033
1.19
0.62
6.8
6.1
umol/l
10.0
11.2
1.47
105
974
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
51
1.59
0.61
2.0
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
20
0.00
0.60
0.0
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
64
729
0.83
0.59
4.3
4.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
7
114
0.60
0.59
1.6
1.8
g/l
1.0
1.2
—
7
102
(3026782) Osmolality of Urine
48
406
1.23
0.58
3.5
2.8
mosm/kgh2o
504.9
546.7
0.99
43
354
(3021901) Oxygen saturation in Capillary blood
6
35
1.73
0.58
5.0
2.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
6
35
1.73
0.58
1.8
1.3
e6/l
15175.0
29214.5
—
6
22
(3020682) Albumin/Creatinine [Ratio] in Urine
66
579
1.20
0.56
5.3
3.8
mg/mmol
4.1
7.5
1.21
35
365
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
34
278
1.26
0.55
1.5
1.3
u/ml
16.9
9.3
0.24
11
104
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
62
1.47
0.54
1.0
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
56
486
1.20
0.53
6.3
7.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
375
1.22
0.50
5.2
3.9
ng/l
248.4
197.5
0.15
38
312
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
172
1.31
0.50
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
172
1.31
0.50
6.0
3.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
15
110
1.39
0.50
3.4
3.2
mmol/l
1.6
2.0
—
8
84
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
102
1.40
0.48
2.4
2.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
84
764
1.16
0.46
3.3
2.6
ug/l
185.4
126.9
0.97
74
688
(3013826) Glucose [Moles/volume] in Serum or Plasma
122
1143
1.15
0.44
4.2
4.4
mmol/l
6.5
6.7
0.31
117
1063
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
51
1.38
0.44
1.9
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
31
1.63
0.43
1.0
1.2
u/l
8.9
8.3
—
5
26
(3039443) Prostate specific Ag panel - Serum or Plasma
5
31
1.63
0.43
1.2
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
213
1.25
0.43
3.3
3.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
18
227
0.77
0.42
3.3
4.5
ug/l
2.2
27.8
0.78
11
190
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
105
1.36
0.42
1.3
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
36
307
1.21
0.42
3.9
1.9
s
32.1
29.7
1.26
36
298
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
58
1.39
0.42
3.8
1.4
g/l
1.2
1.2
—
8
58
(3051651) Icteric interference index of Serum or Plasma
0
17
0.00
0.41
0.0
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
60
1.35
0.40
1.5
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
13
170
0.75
0.40
7.2
5.7
mmol/l
1.4
1.4
0.01
13
162
(3023183) Ammonium ion [Moles/volume] in Plasma
5
35
1.44
0.39
2.2
3.6
umol/l
28.2
38.0
—
5
28
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
41
1.48
0.36
1.0
1.1
mmol/l
3.9
3.9
—
6
36
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
42
1.44
0.36
1.5
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
100
1.32
0.34
1.7
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
201
1.22
0.34
1.6
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
25
211
1.21
0.33
2.0
2.6
umol/l
9.3
9.8
0.04
19
184
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
47
1.28
0.32
1.8
1.3
—
3.6
—
0
6
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
55
1.28
0.30
6.0
1.3
g/l
0.2
0.2
—
7
55
(3023520) Reticulocytes [#/volume] in Blood
21
176
1.21
0.30
2.3
2.7
e9/l
58.2
70.8
1.43
11
135
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
56
1.26
0.29
10.1
2.1
mg/l
2.4
1.7
—
7
48
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
57
1.24
0.29
1.1
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
73
784
0.90
0.29
3.1
4.0
ng/l
20.8
46.8
2.87
54
568
(40768797) Stomach Pathology biopsy report
30
262
1.17
0.28
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
30
341
0.86
0.28
1.4
1.4
g/l
3.3
2.7
0.35
16
202
(3052851) Hemolysis interference index of Serum or Plasma
8
64
1.26
0.28
4.5
3.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
53
484
1.12
0.27
2.6
2.0
mg/l
2.9
3.3
0.48
35
414
(1002224) Polysomnography panel
8
65
1.24
0.27
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
86
1.29
0.26
1.4
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
76
1.19
0.25
2.2
1.9
—
—
—
0
0
(4010399)
11
135
0.81
0.22
2.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
16.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
43
1.17
0.21
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
231
1.14
0.20
1.8
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
21
239
0.87
0.20
6.2
5.9
mmol/l
102.8
103.9
0.41
21
232
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
48
1.26
0.20
1.8
1.3
—
10.3
—
0
10
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
122
0.81
0.19
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
16
138
1.17
0.18
4.8
3.9
%
0.8
0.5
—
6
34
(3022621) pH of Urine by Test strip
12
142
0.84
0.18
2.1
2.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
61
1.15
0.17
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
27
244
1.12
0.17
3.1
2.7
%
1.7
1.8
0.52
22
222
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
12
140
0.85
0.15
3.1
2.7
ml/min/173m2
41.5
62.2
—
6
56
(3009261) Glucose [Presence] in Urine by Test strip
91
945
0.94
0.15
4.0
4.0
estimate
0.0
0.0
0.00
26
179
(3025159) Blasts/100 leukocytes in Blood
16
140
1.15
0.15
5.3
4.0
%
0.1
0.2
—
7
38
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
428
0.92
0.15
3.9
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
112
1.17
0.14
1.7
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
113
1.16
0.13
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
219
1.11
0.13
1.9
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
110
0.81
0.13
1.7
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
57
545
1.06
0.11
4.9
4.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
12
105
1.15
0.11
7.8
7.8
mmol/l
26.4
24.6
0.58
12
98
(3035350) Ketones [Presence] in Urine by Test strip
91
937
0.95
0.11
4.1
4.0
estimate
0.0
0.0
0.00
24
190
(3021601) Nitrite [Presence] in Urine by Test strip
91
936
0.95
0.10
5.5
5.4
estimate
0.0
0.0
0.00
24
186
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(4094501)
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
16
145
1.11
0.09
5.2
4.0
%
0.1
0.2
—
7
44
(3012544) pH of Venous blood
17
186
0.91
0.09
2.2
3.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
16
175
0.91
0.09
2.3
3.4
kpa
6.5
5.8
1.16
16
170
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
107
1.13
0.08
1.3
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
57
1.05
0.08
2.3
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
156
1.10
0.08
5.7
7.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
133
0.90
0.08
1.8
3.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
137
1.10
0.07
1.4
1.6
—
—
—
0
0
(3000492) Spirometry study
13
143
0.90
0.07
2.2
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
83
0.84
0.07
1.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
8
93
0.86
0.07
1.0
1.2
u/ml
39.7
181.9
—
8
83
(3037522) Nuclear Ab [Titer] in Serum
23
217
1.07
0.06
1.5
1.4
titre
825.0
555.6
—
8
54
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
24
253
0.94
0.06
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
58
594
0.97
0.04
3.2
3.0
u/l
29.0
32.7
0.81
53
560
(3003396) Base excess in Arterial blood by calculation
24
229
1.05
0.04
4.9
6.1
mmol/l
2.6
1.1
0.69
18
184
(3025941) Bacteria identified in Stool by Culture
10
109
0.91
0.04
1.7
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
146
1473
0.97
0.04
22.4
20.4
g/l
332.1
331.6
0.32
146
1465
(40760892) CBC W Ordered Manual Differential panel - Blood
41
399
1.03
0.03
5.9
5.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
149
0.94
0.03
4.0
3.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
380
1.03
0.03
1.3
1.2
u/ml
0.9
1.0
0.17
13
105
(3041096) Erythrocytes [Presence] in Urine by Automated
52
530
0.98
0.02
3.7
3.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
143
1.05
0.01
1.3
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
23
223
1.03
0.01
2.0
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
104
1.06
0.01
1.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
17
176
0.96
0.00
2.2
3.4
mmol/l
2.5
2.2
0.11
12
136
(3003694) ABO and Rh group [Type] in Blood
47
476
0.98
0.00
1.5
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
63
624
1.01
0.00
2.8
2.3
u/l
55.0
57.0
0.15
54
574
(3017181) Myelocytes/100 leukocytes in Blood
16
158
1.01
0.00
5.3
3.9
%
2.1
1.0
—
7
50
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
64
638
1.00
0.00
2.4
3.3
ng/l
2108.7
1413.8
0.45
54
533
(1761868) Lipid panel - Serum or Plasma
59
593
0.99
0.00
3.5
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
405
1.02
0.00
1.9
1.8
pmol/l
428.5
457.7
0.25
26
332
(3019309) Folate [Moles/volume] in Red Blood Cells
40
402
0.99
0.00
2.1
1.7
nmol/l
1037.0
1245.0
0.80
24
294
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
106.4
—
0
5
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
93
0.97
0.00
1.8
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
99.0
—
0
9
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
6
0.00
0.00
0.0
3.2
—
83.8
—
0
6
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
78
0.89
0.00
1.3
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
79
1.01
0.00
1.5
1.9
ug/l
2.9
4.9
—
8
73
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
62
0.97
0.00
4.0
4.7
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
5.2
—
26.0
—
0
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
97
0.92
0.00
7.6
6.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
2.6
1.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
10.1
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
13.9
—
1746.3
—
0
8
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
10.5
—
1103.1
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_UPPERLIMB – Melanoma in situ of upper limb, including shoulder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).